Bli medlem
Bli medlem

Du är här


Enea AB: Redeye: Enea - Next Growth Stratum

Redeye maintains its valuation and positive view of Enea, following
our estimate changes yesterday. Shares still trade at a meager 13X
EV/EBIT 21E. We raise our sight, beyond the Corona crisis, and expect
the Stratum deal of USD 15-20m to drive solid growth from 2021.

Read more and download the research update:

Start following companies at Redeye to receive the latest equity
research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment


Författare Cision News